Exact Mass: 459.28069960000005
Exact Mass Matches: 459.28069960000005
Found 87 metabolites which its exact mass value is equals to given mass value 459.28069960000005
,
within given mass tolerance error 0.0002 dalton. Try search metabolite list with more accurate mass tolerance error
4.0E-5 dalton.
N-Docosahexaenoyl Methionine
C27H41NO3S (459.28069960000005)
N-docosahexaenoyl methionine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Docosahexaenoyl amide of Methionine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Docosahexaenoyl Methionine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Docosahexaenoyl Methionine is therefore classified as a very long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
Lys Ala Asn Lys
Ala Ile Arg Thr
Ala Ile Thr Arg
Ala Lys Lys Asn
Ala Lys Asn Lys
Ala Leu Arg Thr
Ala Leu Thr Arg
Ala Asn Lys Lys
Ala Arg Ile Thr
Ala Arg Leu Thr
Ala Arg Thr Ile
Ala Arg Thr Leu
Ala Thr Ile Arg
Ala Thr Leu Arg
Ala Thr Arg Ile
Ala Thr Arg Leu
Gly Lys Lys Gln
Gly Lys Gln Lys
Gly Gln Lys Lys
Ile Ala Arg Thr
Ile Ala Thr Arg
Ile Arg Ala Thr
Ile Arg Thr Ala
Ile Thr Ala Arg
Ile Thr Arg Ala
Lys Ala Lys Asn
Lys Gly Lys Gln
Lys Gly Gln Lys
Lys Lys Ala Asn
Lys Lys Gly Gln
Lys Lys Asn Ala
Lys Lys Gln Gly
Lys Asn Ala Lys
Lys Asn Lys Ala
Lys Gln Gly Lys
Lys Gln Lys Gly
Leu Ala Arg Thr
Leu Ala Thr Arg
Leu Arg Ala Thr
Leu Arg Thr Ala
Leu Thr Ala Arg
Leu Thr Arg Ala
Asn Ala Lys Lys
Asn Lys Ala Lys
Asn Lys Lys Ala
Gln Gly Lys Lys
Gln Lys Gly Lys
Gln Lys Lys Gly
Arg Ala Ile Thr
Arg Ala Leu Thr
Arg Ala Thr Ile
Arg Ala Thr Leu
Arg Ile Ala Thr
Arg Ile Thr Ala
Arg Leu Ala Thr
Arg Leu Thr Ala
Arg Ser Val Val
Arg Thr Ala Ile
Arg Thr Ala Leu
Arg Thr Ile Ala
Arg Thr Leu Ala
Arg Val Ser Val
Arg Val Val Ser
Ser Arg Val Val
Ser Val Arg Val
Ser Val Val Arg
Thr Ala Ile Arg
Thr Ala Leu Arg
Thr Ala Arg Ile
Thr Ala Arg Leu
Thr Ile Ala Arg
Thr Ile Arg Ala
Thr Leu Ala Arg
Thr Leu Arg Ala
Thr Arg Ala Ile
Thr Arg Ala Leu
Thr Arg Ile Ala
Thr Arg Leu Ala
Val Arg Ser Val
Val Arg Val Ser
Val Ser Arg Val
Val Ser Val Arg
Val Val Arg Ser
Val Val Ser Arg
2-[[(4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-4-methylsulfanylbutanoic acid
C27H41NO3S (459.28069960000005)
NA-Met 22:6(4Z,7Z,10Z,13Z,16Z,19Z)
C27H41NO3S (459.28069960000005)